Myriad Genetics buy Piper Sandler
Start price
15.05.25
/
50%
€3.68
Target price
15.05.26
€8.04
Performance (%)
-18.45%
End price
16.05.26
€3.00
Summary
This prediction ended on 16.05.26 with a price of €3.00. The price of Myriad Genetics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.45%. Piper_Sandler has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | 20.751% | 20.751% | 5.291% |
| iShares Core DAX® | -1,36 % | -2,33 % | 3,44 % |
| iShares Nasdaq 100 | -3,70 % | -1,24 % | 33,08 % |
| iShares Nikkei 225® | -2,51 % | 6,91 % | 60,78 % |
| iShares S&P 500 | -1,66 % | -0,64 % | 23,47 % |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Piper Sandler from $12.50 to $9.00. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten